Metraipolis › archive › dc_dc4f6530e2f0

A novel approach to combat Pseudomonas aeruginosa: repurposing pharmaceuticals for inhibition of phospholipase A — Europe PMC PMID:41562599

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41562599
DOI
10.1128/spectrum.01304-25
License (as archived)
solo-consultazione
Archived
2026-10-08T14:50:04.135Z
SHA-256 of the archived text
ffc2112f47bd3750115a35faa5fddb2c3b8d22ce78ec9ecfb55cd41dba3ef69b
Stable URL of this page
https://metraipolis.com/documento/dc_dc4f6530e2f0

How to cite

A novel approach to combat Pseudomonas aeruginosa: repurposing pharmaceuticals for inhibition of phospholipase A — Europe PMC PMID:41562599 — Europe PMC (en), https://europepmc.org/article/MED/41562599 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc4f6530e2f0 (Metraipolis archive dc_dc4f6530e2f0, sha256 ffc2112f47bd3750115a35faa5fddb2c3b8d22ce78ec9ecfb55cd41dba3ef69b)
BibTeX
@misc{dcdc4f6530e2f0,
  title = {A novel approach to combat Pseudomonas aeruginosa: repurposing pharmaceuticals for inhibition of phospholipase A — Europe PMC PMID:41562599},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41562599},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc4f6530e2f0; sha256 ffc2112f47bd3750115a35faa5fddb2c3b8d22ce78ec9ecfb55cd41dba3ef69b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41562599. Agents can read the archived copy with the MCP tool read_document.